March 03, 2025
Your daily dose of the clinical news you may have missed.
February 28, 2025
The Loss of Pulse Detection feature will begin rolling out in the US late next month.
February 28, 2025
The company announced completion of target enrollment in the REZOLVE-AA study of rezpegaldesleukin in people with severe-to-very-severe alopecia areata.
February 28, 2025
Your daily dose of the clinical news you may have missed.
February 27, 2025
Patients with depression from high-wealth areas were 1.62 times more likely in primary care and 1.67 times more likely in psychiatry to use telehealth.
February 27, 2025
The FDA accepted the sNDA for risperidone (Uzedy) extended-release injectable suspension for the maintenance treatment of bipolar I disorder in adults.
February 27, 2025
Your daily dose of the clinical news you may have missed.
February 27, 2025
Your daily dose of the clinical news you may have missed.
February 26, 2025
AAAAI 2025: Phase 2 study results showed POIT with home-measured peanut products was not only highly effective but also posed few risks.
February 26, 2025
Eli Lilly launched 2 new strengths of Zepbound single-dose vials for self-pay patients, and lowered the price of 2.5 mg and 5 mg vials.